ÂÜÀòÂÒÂ×

Zhengyu Liu has a strong background in regulatory affairs, with experience in various therapeutic areas such as oncology, neurology, rare genetic disorders, autoimmune diseases, and more. Currently serving as the Vice President and Head of US Regulatory Affairs at Miltenyi Biomedicine, Zhengyu has also held significant roles at Regulatory Professionals, Idorsia Pharmaceuticals Ltd, LEO Pharma Inc. US, and Sandoz Pharmaceuticals. With a Ph.D. in Pharmacology from the University of Iowa College of Medicine, Zhengyu is a seasoned professional in the field of regulatory affairs.